West China Hospital Thoracic Surgery: Lung, Esophagus and Mediastinal Teams

A department with documented roots and a dated reputation reference

West China Hospital's thoracic surgery department was founded in 1954 by Yang Zhenhua, according to the hospital's own departmental overview. The same page records national key-discipline and clinical-key-specialty recognition and lists subgroup directions covering lung, esophagus, mediastinum, chest wall, minimally invasive surgery and perioperative recovery. The department also founded two journals: the Chinese Journal of Clinical Thoracic and Cardiovascular Surgery in 1994 and the Chinese Journal of Lung Cancer in 1997.

The department placed fourth in the Fudan 2023 national specialty reputation list. This is a historical reference for the department, not a current ranking of its subspecialties or individual surgeons. A patient considering lung cancer surgery, esophageal surgery or thymic surgery would still need the relevant team to assess the particular question. The distinction between those programs is more useful for preparing an enquiry than the hospital's overall reputation alone.

Lung surgery: thoracoscopic technique and locally advanced disease

The hospital's lung surgery program page names Liu Lunxu as academic leader, with Mei Jiandong, Pu Qiang, Ma Lin and Liao Hu listed as clinical contributors. The documented clinical directions include single-direction thoracoscopic lobectomy and surgery for locally advanced lung cancer. Those are descriptions of the program's work, not a statement that every patient with a lung lesion is operable or that a thoracoscopic approach suits every case.

The page also records professional affiliations and editorial work. Liu Lunxu is listed as an FRCS fellow and an AATS member, with relevant editorial roles. Zhou Qinghua is documented for lung-cancer research and a Thoracic Cancer editorial contribution. Membership and editorial service describe professional engagement; they are not outcome awards and do not by themselves establish a current personal appointment.

For a patient, the useful question is not whether a named technique exists somewhere in the department but whether the treating team, after reviewing the actual imaging and pathology, considers that approach appropriate for this cancer, this stage and this lung function. Operability, the extent of resection and the role of any pre-operative treatment are clinical judgements the hospital must make with the patient's own records in hand.

Esophageal surgery: anastomotic technique and treatment sequencing

The esophageal program page names Chen Longqi as academic leader, with Yuan Yong, Hu Yang and Wang Wenping listed as clinical contributors. Documented research and clinical directions include layered esophageal anastomosis, minimally invasive esophageal surgery and surgical questions arising around neoadjuvant treatment.

Chen Longqi is recorded as having contributed to international esophageal-cancer TNM staging, to departmental national clinical pathways and Chinese anticancer guidelines, and to an editorial role with Diseases of Esophagus. These are documented contributions to staging and guideline work. They do not mean that a particular patient's stage has been assigned correctly elsewhere, nor do they set out a treatment sequence that applies to everyone.

An esophageal cancer enquiry can distinguish the diagnosis already established from the treatment decision still unresolved. Has another team proposed surgery, treatment before surgery or a different approach? Ask how the receiving team would review that proposal and which existing reports it needs. A publication or guideline contribution provides context for the program's interests, but the consultation must address the patient's own circumstances rather than simply select a named operation.

Mediastinal surgery: a narrower documented scope

Wang Yun is named academic leader of the mediastinal program. Its stated work includes extended thymectomy for myasthenia gravis and subxiphoid and robot-assisted approaches. This gives the program a distinct focus within thoracic surgery, separate from the lung and esophageal programs.

For an enquiry involving a thymic condition, clarify the diagnosis already recorded and the decision on which another opinion is sought. Ask whether the team can assess the available information and explain the alternatives in that case. The presence of robotic and subxiphoid approaches in a program description does not choose between them for the patient.

Perioperative research: prehabilitation before lung-cancer surgery

The thoracic enhanced recovery research program names Pu Qiang as academic leader. The documented research direction is preoperative pulmonary rehabilitation and assessment in lung-cancer patients with higher-risk factors. This is a perioperative research interest: how patients are prepared and assessed before an operation, particularly when their baseline respiratory reserve is a concern.

For someone already discussing lung surgery, that research raises a useful consultation question: how would the team assess readiness for the proposed operation, and would it recommend any supervised preparation? Describe concerns about breathing, previous treatment or recovery in the enquiry rather than beginning an exercise program based on an article. The perioperative assessment and the eventual discharge plan need to be discussed with the treating clinicians; the research description does not supply a personal recovery timetable.

Honors and technical contributions, correctly attributed

An official hospital feature dated 27 June 2016 records Liu Lunxu as the department's director at that time and describes his 2011 Sichuan Science and Technology Progress First Prize for developing single-direction thoracoscopic lobectomy. The feature connects a specific technical-research contribution with a named recipient. Together with the lung program's account of his work, it explains a documented academic emphasis rather than merely listing an honor without context.

The award and the group's clinical directions answer different questions. The award concerns recognized work; the program page identifies areas in which an assessment might be relevant. Neither establishes that a particular patient should undergo lobectomy, nor confirms that a named clinician will personally undertake a consultation or operation. Ask who would review the case and how the clinical team would communicate its opinion.

Patients sometimes ask to be treated by an award recipient. It is reasonable to ask who will actually be responsible for the assessment and the operation, and how the team is organized around a case. It is not reasonable to expect an editorial article to guarantee that a particular named clinician will see or operate on a particular patient.

Practical decisions before seeking a thoracic appointment

Frame the enquiry around the relevant program and the decision still to be made. For example, is the request about a lung lesion, an established esophageal diagnosis or a thymic condition? Include a brief account of previous assessment and ask which existing imaging, pathology or treatment records the team wants. Confirm whether the proposed next step is a records-based review or an in-person assessment before making travel arrangements.

ChinaSpecialistCare can help organise a thoracic enquiry, prepare records and coordinate visit arrangements after hospital acceptance. We are an independent coordination service, not the hospital, and cannot guarantee a named surgeon or treatment outcome. A brief initial enquiry is free; a proxy consultation is optional rather than required.

Lung and chest surgery in China